Progress in Neurotherapeutics and Neuropsychopharmacology

As this article doesn't contain an abstract, the image below is necessary to enable the article to be indexed by certain search engines. The resolution of the full-text PDF is much higher than that shown here.


Review Article

Introduction to Neurotherapeutics and Neuropsychopharmacology


Jeffrey L. Cummings a1c1
a1 Department of Neurology and Psychiatry & Biobehavioral Sciences, Davids Geffen School of Medicine at UCLA, Los Angeles, CA, USA; Email: jcummings@mednet.ucla.edu

Article author query
cummings jl   [PubMed][Google Scholar] 

Key Words: Neurotherapeutics; psychotropics; clinical trials; drug development; Phase II, Phase III.

Correspondence:
c1 Correspondence should be addressed to: Jeffrey L. Cummings, MD, Department of Neurology, Reed Neurological Research Center, UCLA, 710 Westwood Plaza, Los Angeles, CA 90095 1769, USA; Email: jcummings@mednet.ucla.edu.